ID

13240

Description

Treatment of Non-Hodgkin's Lymphoma With 90Y-hLL2 IgG; ODM derived from: https://clinicaltrials.gov/show/NCT00061425

Link

https://clinicaltrials.gov/show/NCT00061425

Keywords

Versions (1)
  1. 1/25/16 1/25/16 -
Uploaded on

January 25, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

  • Newest
  • Oldest
  • Popular
  • Newest
    • Newest
    • Oldest
    • Popular

    No comments

    In order to download data models you must be logged in. Please log in or register for free.

    Eligibility Non-Hodgkin's Lymphoma NCT00061425

    English

    Eligibility Non-Hodgkin's Lymphoma NCT00061425

    1 forms  
    Criteria
    Description

    Criteria

    histological or cytological diagnosis of b-cell lymphoma, and has failed at least one regimen of standard chemotherapy. (all histological grades of nhl will be eligible for this trial.)
    Description

    b-cell lymphoma, chemotherapy

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0079731
    UMLS CUI [2]
    C0392920
    measureable via ct, with at least one lesion > or = 1.5cm in one or both dimensions. (splenic tumors in absence of other tumors will not qualify.)
    Description

    measureable

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C1513041
    radiological studies (ie - ct) must be performed within 4 weeks prior to study start.
    Description

    radiologic exam

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C2985535
    acceptable tumor burden that will allow adequate follow-up and evaluation.
    Description

    follow-up, evaluation

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C1522577
    UMLS CUI [2]
    C0220825
    less that 25% bone marrow involvement, determined by bone marrow biopsy.
    Description

    bone marrow

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0005953
    at least 4 weeks beyond any major surgery. at least 4 weeks beyond any radiation therapy to the index lesion, and has recovered from radiation-induced toxicity.
    Description

    major surgery, radiation therapy

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0679637
    UMLS CUI [2]
    C1522449
    at least 4 weeks beyond chemotherapy and/or immunotherapy. at least 2 weeks beyond corticosteriod(s) use and blood counts are with laboratory criteria.
    Description

    chemotherapy, immunotherapy, corticosteroids

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0392920
    UMLS CUI [2]
    C0021083
    UMLS CUI [3]
    C0001617
    must have karnofsky score >70% (or equivalent, ecog 0-2) with expected survival of at least 6 months.
    Description

    karnofsky

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0206065
    serum creatinine < or = 1.5mg/dl or creatinine clearance > or = 50ml/min.
    Description

    creatinine, creatinine clearance

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0201976
    UMLS CUI [2]
    C0373595
    serum bilirubin < or = 2mg/dl.
    Description

    bilirubin

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C1278039
    hemoglobin > or = 10 g/dl; wbc > or = 3000/mm3; granulocyte count > or = 150/mm3; platelet count > or = 100,000/mm3 with out transfusions or cytokines for at least 30 days prior to study.
    Description

    hemoglobin, granulocyte count, transfusions, cytokines

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0518015
    UMLS CUI [2]
    C0857490
    UMLS CUI [3]
    C0032181
    UMLS CUI [4]
    C1879316
    UMLS CUI [5]
    C0199974
    immunomedics elisa assay of hahll2 < 100ng/ml for those with prior history of monoclonal antibody infusions.
    Description

    human anti-human antibodies

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C3641682
    cognizant informed consent.
    Description

    informed consent

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0021430
    Back to the top of the page

    Similar models

    Eligibility Non-Hodgkin's Lymphoma NCT00061425

    1 forms
    Name
    Type
    Description | Question | Decode (Coded Value)
    Data type
    Alias
    Item Group
    b-cell lymphoma, chemotherapy
    Item
    histological or cytological diagnosis of b-cell lymphoma, and has failed at least one regimen of standard chemotherapy. (all histological grades of nhl will be eligible for this trial.)
    boolean
    C0079731 (UMLS CUI [1])
    C0392920 (UMLS CUI [2])
    measureable
    Item
    measureable via ct, with at least one lesion > or = 1.5cm in one or both dimensions. (splenic tumors in absence of other tumors will not qualify.)
    boolean
    C1513041 (UMLS CUI [1])
    radiologic exam
    Item
    radiological studies (ie - ct) must be performed within 4 weeks prior to study start.
    boolean
    C2985535 (UMLS CUI [1])
    follow-up, evaluation
    Item
    acceptable tumor burden that will allow adequate follow-up and evaluation.
    boolean
    C1522577 (UMLS CUI [1])
    C0220825 (UMLS CUI [2])
    bone marrow
    Item
    less that 25% bone marrow involvement, determined by bone marrow biopsy.
    boolean
    C0005953 (UMLS CUI [1])
    major surgery, radiation therapy
    Item
    at least 4 weeks beyond any major surgery. at least 4 weeks beyond any radiation therapy to the index lesion, and has recovered from radiation-induced toxicity.
    boolean
    C0679637 (UMLS CUI [1])
    C1522449 (UMLS CUI [2])
    chemotherapy, immunotherapy, corticosteroids
    Item
    at least 4 weeks beyond chemotherapy and/or immunotherapy. at least 2 weeks beyond corticosteriod(s) use and blood counts are with laboratory criteria.
    boolean
    C0392920 (UMLS CUI [1])
    C0021083 (UMLS CUI [2])
    C0001617 (UMLS CUI [3])
    karnofsky
    Item
    must have karnofsky score >70% (or equivalent, ecog 0-2) with expected survival of at least 6 months.
    boolean
    C0206065 (UMLS CUI [1])
    creatinine, creatinine clearance
    Item
    serum creatinine < or = 1.5mg/dl or creatinine clearance > or = 50ml/min.
    boolean
    C0201976 (UMLS CUI [1])
    C0373595 (UMLS CUI [2])
    bilirubin
    Item
    serum bilirubin < or = 2mg/dl.
    boolean
    C1278039 (UMLS CUI [1])
    hemoglobin, granulocyte count, transfusions, cytokines
    Item
    hemoglobin > or = 10 g/dl; wbc > or = 3000/mm3; granulocyte count > or = 150/mm3; platelet count > or = 100,000/mm3 with out transfusions or cytokines for at least 30 days prior to study.
    boolean
    C0518015 (UMLS CUI [1])
    C0857490 (UMLS CUI [2])
    C0032181 (UMLS CUI [3])
    C1879316 (UMLS CUI [4])
    C0199974 (UMLS CUI [5])
    human anti-human antibodies
    Item
    immunomedics elisa assay of hahll2 < 100ng/ml for those with prior history of monoclonal antibody infusions.
    boolean
    C3641682 (UMLS CUI [1])
    informed consent
    Item
    cognizant informed consent.
    boolean
    C0021430 (UMLS CUI [1])
    Back to the top of the page 

    Help

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial